Carocell Bio Selected as Finalist for RESI Innovator’s Pitch Challenge

RESI Innovator’s Pitch Challenge

GREATER MANCHESTER, UK – 6 June 2022 – Today, Carocell Bio, the anti-inflammation company revolutionising the treatment of inflammatory diseases with its peptide-based approach to mitogen-activated protein kinase inhibition (MAPKi), announced that it had been selected to pitch to investors at the Redefining Early Stage Investments (RESI) Digital Innovator’s Pitch Challenge. The pitching event, taking place […]